DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Appeal No. 7075 of 2026 filed by Vipan Kumar

SEBI 1 hr ago·1 Oct 2026, 12:30 pm

Company SEBI

An appeal has been filed in the Supreme Court, marking a significant development in the ongoing legal proceedings. This specific legal action is expected to influence the broader market environment and could alter the regulatory landscape for various sectors.

For investors, this news highlights the importance of monitoring legal risks and regulatory shifts. While the immediate impact on individual stocks is uncertain, the broader market sentiment may be affected as investors react to potential changes in the regulatory framework.

Investors should keep a close watch on official updates regarding the appeal. Understanding the court's stance and the subsequent regulatory changes will be crucial for making informed investment decisions in the coming days.